Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.9B |
| 2 |
Boeing
BA
|
+$956M |
| 3 |
Netflix
NFLX
|
+$804M |
| 4 |
EOG Resources
EOG
|
+$761M |
| 5 |
Wells Fargo
WFC
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$1.3B |
| 2 |
Nike
NKE
|
+$1.17B |
| 3 |
AbbVie
ABBV
|
+$1.16B |
| 4 |
McDonald's
MCD
|
+$1.15B |
| 5 |
Texas Instruments
TXN
|
+$987M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.27% |
| 2 | Technology | 16.8% |
| 3 | Communication Services | 12.6% |
| 4 | Consumer Discretionary | 11.05% |
| 5 | Financials | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Accenture
ACN
$110B
| $3.09B | 0.93% |
14,671,063
-1,228,301
| -8% | -$239M |
|
27
Vale
VALE
$61.4B
| $2.98B | 0.89% |
225,652,937
+3,429,054
| +2% | +$41.2M |
|
28
Canadian Natural Resources
CNQ
$98.1B
| $2.92B | 0.88% |
184,220,261
+4,203,845
| +2% | +$57.1M |
|
29
Humana
HUM
$46.7B
| $2.87B | 0.86% |
7,829,472
+1,033,910
| +15% | +$328M |
|
30
CME Group
CME
$94.3B
| $2.73B | 0.82% |
13,595,685
+250,389
| +2% | +$51.4M |
|
31
Illumina
ILMN
$29.1B
| $2.65B | 0.79% |
8,209,887
+80,870
| +1% | +$24.5M |
|
32
Dominion Energy
D
$59.8B
| $2.61B | 0.78% |
31,571,388
+459,388
| +1% | +$37.5M |
|
33
Marriott International
MAR
$92.5B
| $2.38B | 0.71% |
15,718,068
-24,697
| -0.2% | -$3.31M |
|
34
Lockheed Martin
LMT
$140B
| $2.27B | 0.68% |
5,842,102
-157,945
| -3% | -$60.6M |
|
|
CXO
35
DELISTED
CONCHO RESOURCES INC.
CXO
| $2.15B | 0.65% |
24,583,880
+423,417
| +2% | +$30.6M |
|
36
Autodesk
ADSK
$52.7B
| $2.11B | 0.63% |
11,491,718
+306,710
| +3% | +$49.7M |
|
37
Mercado Libre
MELI
$92.7B
| $2.07B | 0.62% |
3,623,338
+864,708
| +31% | +$479M |
|
38
American Electric Power
AEP
$67.9B
| $2.06B | 0.62% |
21,849,296
-634,071
| -3% | -$58.6M |
|
39
Apple
AAPL
$4.41T
| $2.01B | 0.6% |
27,380,216
+1,529,208
| +6% | +$98.4M |
|
40
Stryker
SYK
$133B
| $2B | 0.6% |
9,515,302
-2,568,110
| -21% | -$533M |
|
41
Costco
COST
$421B
| $2B | 0.6% |
6,794,601
-1,147,265
| -14% | -$341M |
|
42
Crown Castle
CCI
$31.5B
| $1.97B | 0.59% |
13,830,667
+4,273,280
| +45% | +$583M |
|
43
Cigna
CI
$73.3B
| $1.94B | 0.58% |
9,490,059
+2,810
| +0% | +$515K |
|
|
44
Nike
NKE
$60.1B
| $1.9B | 0.57% |
18,789,590
-12,439,256
| -40% | -$1.17B |
|
45
Verizon
VZ
$195B
| $1.87B | 0.56% |
30,425,221
-5,893,525
| -16% | -$355M |
|
46
BioMarin Pharmaceuticals
BMRN
$13.6B
| $1.86B | 0.56% |
22,004,065
+296,401
| +1% | +$22.4M |
|
|
47
Fidelity National Information Services
FIS
$21.6B
| $1.83B | 0.55% |
13,168,151
-9,727,139
| -42% | -$1.3B |
|
48
Diamondback Energy
FANG
$56.2B
| $1.82B | 0.55% |
19,577,175
+5,391,907
| +38% | +$448M |
|
49
Alcon
ALC
$35.6B
| $1.8B | 0.54% |
31,824,542
+10,970,060
| +53% | +$628M |
|
50
TC Energy
TRP
$66.3B
| $1.74B | 0.52% |
32,733,187
+16,960
| +0.1% | +$870K |
|
Similar funds
Capital Research Global Investors's Q4 2019 Portfolio in Review
As of Q4 2019, Capital Research Global Investors held 433 positions worth $333B, up 9.4% from $305B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capital Research Global Investors's Q4 2019 filing shows 19 new, 239 increased, 105 reduced and 28 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 415,754 shares worth $490M. The largest sale was Fidelity National Information Services, an estimated $1.3B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Communication Services.
- Capital Research Global Investors's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 415,754 shares worth $490M.
- Capital Research Global Investors added most to UnitedHealth in Q4 2019, an estimated $1.9B increase.
- Capital Research Global Investors's biggest Q4 2019 reduction was Fidelity National Information Services, cutting an estimated $1.3B.
- Capital Research Global Investors fully exited 3M in Q4 2019, selling an estimated $654M.
- Capital Research Global Investors's ten largest holdings make up 30% of its $333B portfolio in Q4 2019.
- Capital Research Global Investors opened 19 new positions and closed 28 in Q4 2019.
- Capital Research Global Investors's portfolio value rose 9.4% quarter-over-quarter to $333B.
Based on Capital Research Global Investors's 13F filing for Q4 2019, filed 18 Feb 2020.